Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

Trading Update

19 Oct 2011 07:00

RNS Number : 4400Q
BowLeven Plc
19 October 2011
 

19 October 2011

 

Bowleven plc ("Bowleven" or the "Company")

 

Trading Update

 

The Company will announce its Preliminary Results for the year ended 30 June 2011 on Thursday 3 November. The Company's financial results remain in draft form and are still subject to final approval by the Directors and the auditors before release. A copy of the Preliminary Results announcement will also be made available on the Company's website at www.bowleven.com. The Preliminary Results announcement is expected to include, amongst other things, details of the following:-

·; Resources Update

The Preliminary Results will contain the annual updated contingent resources position (on a net basis) for the Group. The principal movement to the previous year's resources position will be the inclusion of the Sapele Omicron discoveries made during the period. The initial in place volumetrics for these discoveries have already been announced to the market. The range of recovery factors then applied to the volumetrics to derive the resource figures will be in line with the guidance previously provided.

This update will exclude the impact on volumetrics for the net pay intervals encountered in the Sapele-3 well which will be provided in due course.

·; EOV Permit, Gabon

As previously announced, an agreement in principle has been reached with a third party to sell GGPC (EOV) Gabon Limited, the Bowleven Group subsidiary that is the licensee and operator of the EOV Permit. Assets relating to GGPC Gabon (EOV) Limited have been re-classified to assets held-for-sale on the balance sheet in anticipation of the completion of the disposal of this acreage. The assets held for sale figure represents disposal proceeds of US$35 million plus provisional working capital movements since July 2009.

·; Epaemeno Permit, Gabon

The Epaemeno Permit, onshore Gabon has been relinquished following a joint technical review of prospectivity carried out by the Operator, Addax, and Bowleven. This is likely to result in unsuccessful exploration costs of approximately US$42 million being charged to the Income Statement in the financial year ending 30 June 2011 for the write off of the asset. This is a non-cash adjustment.

·; Foreign Exchange Movements (intra Group funding)

The Results for the year will include finance costs which are being charged to the Income Statement of approximately US$23 million, which is primarily occurring from the recognition of foreign exchange movements on intra-group funding under IFRS as the US Dollar weakened against Sterling over the comparative period. This is also a non-cash adjustment.

The financial statements will be prepared on a going concern basis as they anticipate the completion of the proposed placing of shares to be announced today ("the Placing"). Without the additional funding contemplated by the Placing there would be a significant impact on the Company's ability to carry out its proposed 2012 work programme and also to finance its working capital requirements through 2012.

 

As at 31 October 2011, after taking into account all budgeted and approved drilling costs on Sapele-3, but excluding any provision for testing, it is estimated that the Company will have approximately US$15 million in net cash.

 

ENQUIRIES

For further information please contact:

 

Bowleven plc

00 44 131 524 5678

Kevin Hart, Chief Executive

Kerry Crawford, Head of Investor Relations

 

BofA Merrill Lynch (Nomad)

00 44 207 628 1000

Andrew Osborne

Tony White

Brunswick Group LLP

Patrick Handley

Natalia Erikssen

00 44 207 404 5959

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGUBDGUSBBGBC
Date   Source Headline
8th Dec 202111:53 amRNSRESULT OF ANNUAL GENERAL MEETING
15th Nov 20217:00 amRNSPosting of Annual Report and Accounts 2021
10th Nov 202111:05 amRNSSecond Price Monitoring Extn
10th Nov 202111:00 amRNSPrice Monitoring Extension
10th Nov 20217:00 amRNSFull Year Results
9th Nov 20218:55 amRNSBlock Admission Six Monthly Return
20th Aug 20214:41 pmRNSSecond Price Monitoring Extn
20th Aug 20214:36 pmRNSPrice Monitoring Extension
20th Aug 20212:05 pmRNSSecond Price Monitoring Extn
20th Aug 20212:00 pmRNSPrice Monitoring Extension
20th Aug 202111:05 amRNSSecond Price Monitoring Extn
20th Aug 202111:00 amRNSPrice Monitoring Extension
20th Aug 20219:05 amRNSSecond Price Monitoring Extn
20th Aug 20219:00 amRNSPrice Monitoring Extension
24th May 20212:06 pmRNSSecond Price Monitoring Extn
24th May 20212:00 pmRNSPrice Monitoring Extension
14th May 202111:05 amRNSSecond Price Monitoring Extn
14th May 202111:00 amRNSPrice Monitoring Extension
13th May 202111:06 amRNSSecond Price Monitoring Extn
13th May 202111:00 amRNSPrice Monitoring Extension
10th May 20219:15 amRNSBlock Admission Six Monthly Return
30th Mar 20212:05 pmRNSSecond Price Monitoring Extn
30th Mar 20212:01 pmRNSPrice Monitoring Extension
30th Mar 20219:05 amRNSSecond Price Monitoring Extn
30th Mar 20219:00 amRNSPrice Monitoring Extension
30th Mar 20217:00 amRNSInterim Results
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn
19th Mar 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20219:05 amRNSSecond Price Monitoring Extn
16th Mar 20219:00 amRNSPrice Monitoring Extension
3rd Mar 20217:00 amRNSHolding(s) in Company
12th Feb 202111:06 amRNSSecond Price Monitoring Extn
12th Feb 202111:00 amRNSPrice Monitoring Extension
27th Jan 20215:50 pmRNSTR-1: Notification of major holdings
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSEtinde Exploitation Authorisation Agreement
11th Jan 20217:00 amRNSAppointment of Chairman
31st Dec 202012:35 pmRNSPrice Monitoring Extension
30th Dec 20204:41 pmRNSSecond Price Monitoring Extn
30th Dec 20204:36 pmRNSPrice Monitoring Extension
17th Dec 20204:36 pmRNSPrice Monitoring Extension
16th Dec 20204:35 pmRNSPrice Monitoring Extension
9th Dec 202011:06 amRNSResult of Annual General Meeting
30th Nov 20204:41 pmRNSSecond Price Monitoring Extn
30th Nov 20204:36 pmRNSPrice Monitoring Extension
26th Nov 20204:41 pmRNSSecond Price Monitoring Extn
26th Nov 20204:35 pmRNSPrice Monitoring Extension
24th Nov 20204:40 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.